Home › Funds › NVP Associates, LLC › MBX

NVP Associates, LLC position in MBX

MBX BIOSCIENCES INC · Health Care

NVP Associates, LLC reported holding 2,136,335 shares of MBX (MBX BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$125.2M, representing 44.42% of its reported portfolio and ranking #1 among its reported holdings. NVP Associates, LLC has disclosed MBX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)2.14M sh
Reported value held$125.23M
Portfolio Weight44.42%
First reportedQ3 2024
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How NVP Associates, LLC's MBX position evolved

NVP Associates, LLC first disclosed a stake in MBX in Q3 2024 at 2,136,335 shares (US$55.5M). The position peaked in Q3 2026 at 2,136,335 shares, worth US$125.2M. Across 9 filings, NVP Associates, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 2,136,335 shares valued at US$125.2M.

Quarter by quarter

QuarterSharesValueChange
Q3 2024 2.14M $55.50M New
Q4 2024 2.14M $39.37M Hold
Q1 2025 2.14M $15.77M Hold
Q2 2025 2.14M $24.38M Hold
Q3 2025 2.14M $37.39M Hold
Q4 2025 2.14M $67.38M Hold
Q1 2026 2.14M $63.77M Hold
Q2 2026 2.14M $117.93M Hold
Q3 2026 2.14M $125.23M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MBX and 13F data

MBX (MBX BIOSCIENCES INC) is a Health Care company. 69 other funds we track also report a position in MBX — the largest reported positions include Frazier Life Sciences Management, L.P. (US$367.2M), NEA Management Company, LLC (US$199.5M), ORBIMED ADVISORS LLC (US$189.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MBX

All MBX fund holders →

FAQ

How long has NVP Associates, LLC held MBX?

NVP Associates, LLC has disclosed MBX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is NVP Associates, LLC's current position in MBX?

As of Q3 2026, NVP Associates, LLC holds 2.14M shares of MBX (MBX BIOSCIENCES INC), valued at $125.23M, representing 44.42% of its reported portfolio and ranking #1.

Has NVP Associates, LLC been buying or selling MBX?

In the latest 13F filing (Q3 2026), NVP Associates, LLC held unchanged its position in MBX. The position peaked in Q3 2026 at 2.14M shares.

Which other funds hold MBX?

Other major institutional holders of MBX include Frazier Life Sciences Management, L.P., NEA Management Company, LLC, ORBIMED ADVISORS LLC, among 69 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.